Biotech M&A rolls on as Alex ion snaps up Wilson for $855 mln

(Reuters) - Alex ion Pharmaceuticals has agreed to buy Sweden's Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting its line-up of rare disease drugs as a wave of deal-making in the biotechnology sector continues.